NEW YORK (GenomeWeb) – Scientists this week described a new mechanism by which Cas9 proteins can target viral RNA.

In a paper published in the Proceedings of the National Academy of Sciences, the researchers from Emory University detailed the use of a Cas9 variant from the gram-negative bacterium Francisella novicida that can inhibit viral protein production from hepatitis C virus (HCV) RNA.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers test gene therapy targeting a different cancer protein in a new trial, the New York Times reports.

Pennsylvania State University researchers found that salivary microRNAs could predict which kids would have longer concussion symptoms, according to NPR.

The Associated Press reports Alex Azar, the new Department of Health and Human Services secretary nominee, made millions of dollars as a pharmaceutical executive.

In PNAS this week: immune profiling of breast cancer, transposable element patterns in rice, and more.